Statin use linked to reduction in risks for all-cause dementia and Alzheimer disease-related dementia
WEDNESDAY, April 9, 2025 (HealthDay News) — Low low-density lipoprotein cholesterol (LDL-C) levels are associated with a reduced risk for dementia, including Alzheimer disease-related dementia (ADRD), according to a study published online April 1 in the Journal of Neurology, Neurosurgery & Psychiatry.
Minwoo Lee, M.D., Ph.D., from Hallym University College of Medicine in Anyang, South Korea, and colleagues examined the association between low LDL-C levels and the risk for dementia and assessed the influence of statin therapy in a retrospective analysis of data from 11 university hospitals participating in the Observational Medical Outcomes Partnership Common Data Model. A primary analysis cohort of 108,980 propensity score-matched patients compared individuals with LDL-C levels less than 70 mg/dL to those with levels greater than 130 mg/dL.
The researchers found a 26 percent reduction in the risk for all-cause dementia and a 28 percent reduction in the risk for ADRD in association with LDL-C levels below 70 mg/dL versus greater than 130 mg/dL. An 18 percent risk reduction for both outcomes was seen for LDL-C levels below 55 mg/dL. Statin use versus nonuse was associated with a 13 and 12 percent reduction in the risks for all-cause dementia and ADRD, respectively.
“These findings underscore the crucial role of managing LDL-C in lowering dementia risk and highlight the importance of targeted strategies in addressing cardiovascular and cognitive health outcomes by physicians,” the authors write.
Lifetime Exposure to Cognitive Enrichment Linked to Lower Dementia Risk
Meta-Analysis Identifies Few Adverse Events Attributed to Statin Use
Collaborative Dementia Care Offers Health, Economic Benefits
Cognitive Speed Training Plus Booster Linked to Lower Risk for Dementia
Greater Intake of Caffeinated Coffee, Tea May Reduce Dementia Risk
Chronic Traumatic Encephalopathy Linked to Dementia
High BMI Linked to Higher Risk for Vascular-Related Dementia
Many Older Adults Receive Potentially Inappropriate CNS-Active Meds